259 related articles for article (PubMed ID: 25260308)
1. Surveillance for hepatocellular carcinoma.
Sherman M
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):783-93. PubMed ID: 25260308
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for hepatocellular carcinoma: how can we do better?
Hassett M; Yopp AC; Singal AG
Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for hepatocellular carcinoma.
Frenette C
Clin Adv Hematol Oncol; 2016 Jun; 14(6):407-9. PubMed ID: 27379808
[No Abstract] [Full Text] [Related]
4. Controversies in surveillance and early diagnosis of hepatocellular carcinoma.
Kim DY; Kim JW; Kuromatsu R; Ahn SH; Torimura T; Sherman M
Oncology; 2011; 81 Suppl 1():56-60. PubMed ID: 22212937
[TBL] [Abstract][Full Text] [Related]
5. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
Amarapurkar D; Han KH; Chan HL; Ueno Y;
J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
[TBL] [Abstract][Full Text] [Related]
6. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
Trinchet JC; Nahon P; Ganne-Carrie N
Rev Prat; 2013 Feb; 63(2):222-5. PubMed ID: 23513790
[TBL] [Abstract][Full Text] [Related]
7. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
8. Screening and detection of hepatocellular carcinoma.
Simpson HN; McGuire BM
Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
[TBL] [Abstract][Full Text] [Related]
9. Screening and surveillance for hepatocellular carcinoma: perspective of a new era?
Maida M; Malizia G; Affronti A; Virdone R; Maida C; Margherita V; D'amico G
Expert Rev Anticancer Ther; 2016 Dec; 16(12):1291-1302. PubMed ID: 27730841
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
Kanwal F; Singal AG
Gastroenterology; 2019 Jul; 157(1):54-64. PubMed ID: 30986389
[TBL] [Abstract][Full Text] [Related]
11. Current Practice of Hepatocellular Carcinoma Surveillance.
Loho IM; Siregar L; Waspodo AS; Hasan I
Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
[TBL] [Abstract][Full Text] [Related]
12. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong RJ; Ahmed A; Gish RG
Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
[TBL] [Abstract][Full Text] [Related]
13. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma surveillance in patients with alcoholic cirrhosis.
Jepsen P; Ott P
Expert Rev Gastroenterol Hepatol; 2012 Dec; 6(6):651-3. PubMed ID: 23237248
[No Abstract] [Full Text] [Related]
15. Surveillance for Hepatocellular Carcinoma.
Marrero JA
Clin Liver Dis; 2020 Nov; 24(4):611-621. PubMed ID: 33012448
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?
Poustchi H; Farrell GC; Strasser SI; Lee AU; McCaughan GW; George J
Hepatology; 2011 Dec; 54(6):1998-2004. PubMed ID: 21800340
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
Giannini EG; Farinati F; Trevisani F
Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
[No Abstract] [Full Text] [Related]
18. Surveillance for hepatocellular carcinoma.
Díaz-González Á; Forner A
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):1001-1010. PubMed ID: 27938779
[TBL] [Abstract][Full Text] [Related]
19. α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.
El-Serag HB; Kanwal F
Clin Gastroenterol Hepatol; 2013 Apr; 11(4):441-3. PubMed ID: 23376321
[No Abstract] [Full Text] [Related]
20. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
